Ponce, Pilar, NONE. S.

HRN: 04-43-02  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/20/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/20/2022
10/27/2022
IV
2.25 G
Q6
Urosepsis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: